Current Build

V2-0477.vs.xml

Vocabulary Work GroupMaturity Level: N/AStandards Status: Informative

Raw XML (canonical form + also see XML Format Specification)

FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)

<?xml version="1.0" encoding="UTF-8"?>

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="v2-0477"/> 
  <meta> 
    <profile value="http://hl7.org/fhir/StructureDefinition/shareablevalueset"/> 
  </meta> 
  <language value="en"/> 
  <text> 
    <status value="additional"/> 
    <div xmlns="http://www.w3.org/1999/xhtml">
      <p> Controlled Substance Schedule</p> 

      <table class="grid">
        <tr> 
          <td> 
            <b> Code</b> 
          </td> 
          <td> 
            <b> Description</b> 
          </td> 
          <td> 
            <b> Comment</b> 
          </td> 
          <td> 
            <b> Version</b> 
          </td> 
        </tr> 
        <tr> 
          <td> I
            <a name="I"> </a> 
          </td> 
          <td> Schedule I</td> 
          <td> Includes drugs that have a high potential for abuse, no currently accepted medical use
               in the United States and a lack of accepted safety for use under medical supervision.</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> II
            <a name="II"> </a> 
          </td> 
          <td> Schedule II</td> 
          <td> Includes drugs having currently accepted medical use in the United States and a high abuse
               potential, with severe psychological or physical dependence liability.</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> III
            <a name="III"> </a> 
          </td> 
          <td> Schedule III</td> 
          <td> Includes drugs having an abuse potential less than that of drugs listed in Schedules I
               and II. All CS III drugs have a currently accepted medical use in the United States.</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> IV
            <a name="IV"> </a> 
          </td> 
          <td> Schedule IV</td> 
          <td> Includes drugs having a lesser potential for abuse than those listed in Schedule III.
               CS IV drugs have a currently accepted medical use in the United States.</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> V
            <a name="V"> </a> 
          </td> 
          <td> Schedule V</td> 
          <td> Includes drugs having low abuse potential and limited physical or psychological dependence
               relative to those listed in IV and have an accepted medical use in the United States.</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> VI
            <a name="VI"> </a> 
          </td> 
          <td> Schedule VI</td> 
          <td> State defined</td> 
          <td> added v2.5</td> 
        </tr> 
      </table> 

    </div> 
  </text> 
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
    <valueCode value="external"/> 
  </extension> 
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
    <valueInteger value="0"/> 
  </extension> 
  <url value="http://terminology.hl7.org/ValueSet/v2-0477"/> 
  <version value="2.9"/> 
  <name value="v2.0477"/> 
  <title value="v2 Controlled Substance Schedule"/> 
  <status value="active"/> 
  <experimental value="false"/> 
  <publisher value="HL7, Inc"/> 
  <contact> 
    <telecom> 
      <system value="url"/> 
      <value value="http://hl7.org"/> 
    </telecom> 
  </contact> 
  <description value="FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)"/> 
  <immutable value="true"/> 
  <compose> 
    <include> 
      <system value="http://terminology.hl7.org/CodeSystem/v2-0477"/> 
    </include> 
  </compose> 
</ValueSet> 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.